| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |